Karyopharm Therapeutics
KPTI
KPTI
89 hedge funds and large institutions have $248M invested in Karyopharm Therapeutics in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
59% less capital invested
Capital invested by funds: $610M → $248M (-$362M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
89
Holding in Top 10
–
Calls
$9.77M
Puts
$2.27M
Top Buyers
| 1 | +$14.3M | |
| 2 | +$9.55M | |
| 3 | +$6.96M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4.65M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.63M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$9.77M | |
| 3 | -$5.76M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.84M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$2.68M |